REGENTIS BIOMATERIALS LTD. - RGNT
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | History | Added to | 701,685 | 2,476 | 0.92% | 0.31% | 1 | +450,175 | 178.99% | Q2 2026 | Aug 14, 2026 |
| Warberg Asset Management LLC | History | New | 86,980 | 306 | 0.06% | — | 2 | +86,980 | New | Q2 2026 | Aug 11, 2026 |
| JANE STREET GROUP, LLC | History | New | 43,333 | 152 | 0.0% | — | 3 | +43,333 | New | Q2 2026 | Aug 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | History | New | 13,348 | 47 | 0.0% | — | 4 | +13,348 | New | Q2 2026 | Aug 13, 2026 |
| UBS Group AG | History | Added to | 434 | 1 | 0.0% | 0.0% | 5 | +100 | 29.94% | Q2 2026 | Aug 13, 2026 |
| AIGH Capital Management LLC | History | Closed out | 0 | 0 | — | 0.12% | — | -300,000 | -100.0% | Q2 2026 | Aug 07, 2026 |
| Tower Research Capital LLC (TRC) | History | New | 11 | 0 | — | — | — | +11 | New | Q2 2026 | Aug 11, 2026 |